Type II Variation [Regulatives / Guidelines]

posted by Elena – Macedonia, 2013-09-18 10:42 (4661 d 21:37 ago) – Posting: # 11512
Views: 6,308

Hi Helmut,

Thank you for your reply. This really helps.

We are still in developing phase and consider the size of the biobatch.

Just to be sure, if the biobatch is < 100,000 units and the scale-up is up to 10 fold, a type II Variation is needed, supported by a Bioequivalence study?

Kind regards,

Elena

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
128 visitors (0 registered, 128 guests [including 15 identified bots]).
Forum time: 08:20 CEST (Europe/Vienna)

Scientists often have a naïve faith that
if only they could discover enough facts about a problem,
these facts would somehow arrange themselves
in a compelling and true solution.    Theodosius Dobzhansky

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5